Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 90,897,000	$ 63,412,000
General and administrative	28,058,000	23,017,000
Total operating expenses	118,955,000	86,429,000
Loss from operations	(118,955,000)	(86,429,000)
Other income (expense), net:
Interest income	5,588,000	370,000
Other expense, net	(470,000)	(16,000)
Total other income (expense), net	5,118,000	354,000
Net loss	(113,837,000)	(86,075,000)
Comprehensive loss:
Net loss	(113,837,000)	(86,075,000)
Other comprehensive loss:
Unrealized loss on securities	(529,000)	(153,000)
Comprehensive loss	$ (114,366,000)	$ (86,228,000)
Net loss per share, basic	$ (2.61)	$ (2.62)
Earnings Per Share, Diluted	$ (2.61)	$ (2.62)
Weighted-average number of common shares used in net loss per share, basic	43,631,722	32,856,883
Weighted-average number of common shares used in net loss per share, diluted	43,631,722	32,856,883